No Data
No Data
Lexeo Stock Drops 24% Amid Friedreich Ataxia Study Results
Express News | Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LEXINGTON, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, has entered into an employment
Several Voyager Therapeutics Insiders Sell Shares Sending Potential Negative Signal
Voyager Therapeutics, Inc. (NASDAQ:VYGR) shareholders may have reason to be concerned, as several insiders sold their shares over the past year. When analyzing insider transactions, it is usually mo
Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer
LEXINGTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced the appointment
Voyager Therapeutics to Present at Multiple Virtual Investor Conferences
LEXINGTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the company
No Data